Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes.

[1]  E. Lakatta,et al.  Heterodimerization of β1- and β2-Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility , 2005 .

[2]  N. Farhat,et al.  Sub-cellular distribution of endothelin signaling pathway components in ventricular myocytes and heart: lack of preformed caveolar signalosomes. , 2005, Journal of molecular and cellular cardiology.

[3]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[4]  Susan S. Taylor,et al.  A-kinase-interacting protein localizes protein kinase A in the nucleus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Gerdes,et al.  Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[6]  M. Scott,et al.  Localization Sequence Contains a DNA-Binding Nuclear G Protein-Coupled Receptor Kinase 5 , 2004 .

[7]  S. Steinberg.  beta(2)-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts. , 2004, Journal of molecular and cellular cardiology.

[8]  Heping Cheng,et al.  Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications , 2004 .

[9]  B. O'dowd,et al.  Agonist-independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2 Receptors* , 2004, Journal of Biological Chemistry.

[10]  A. Schinkel,et al.  Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3) , 2004, Journal of Pharmacology and Experimental Therapeutics.

[11]  Martin J. Lohse,et al.  What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.

[12]  S. Burchett,et al.  In through the out door: nuclear localization of the regulators of G protein signaling , 2003, Journal of neurochemistry.

[13]  E. Goetzl,et al.  Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1* , 2003, Journal of Biological Chemistry.

[14]  W. Stroud,et al.  Persistence of Golgi Matrix Distribution Exhibits the Same Dependence on Sar1p Activity as a Golgi Glycosyltransferase , 2003, Traffic.

[15]  É. Rousseau,et al.  Functional Endothelin Receptors Are Present on Nuclei in Cardiac Ventricular Myocytes* , 2003, Journal of Biological Chemistry.

[16]  A. Burkhalter,et al.  Activation of Metabotropic Glutamate Receptor mGlu5 on Nuclear Membranes Mediates Intranuclear Ca2+ Changes in Heterologous Cell Types and Neurons* , 2003, Journal of Biological Chemistry.

[17]  H. Granger,et al.  β3-Adrenergic Receptors Regulate Retinal Endothelial Cell Migration and Proliferation* , 2003, Journal of Biological Chemistry.

[18]  S. Steinberg,et al.  Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains. , 2003, Molecular pharmacology.

[19]  Ping Wang,et al.  Subcellular Localization of β-Arrestins Is Determined by Their Intact N Domain and the Nuclear Export Signal at the C Terminus* , 2003, The Journal of Biological Chemistry.

[20]  B. Boivin,et al.  Regulation of membrane-bound PKC in adult cardiac ventricular myocytes. , 2003, Cellular signalling.

[21]  T. Hébert,et al.  Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers. , 2003, Canadian journal of physiology and pharmacology.

[22]  S. Choufani,et al.  Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor1 , 2002, The Journal of Immunology.

[23]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[24]  S. Benichou,et al.  Differential Nucleocytoplasmic Shuttling of β-Arrestins , 2002, The Journal of Biological Chemistry.

[25]  E. Lakatta,et al.  β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.

[26]  A. Wells,et al.  Signalling shortcuts: cell-surface receptors in the nucleus? , 2002, Nature Reviews Molecular Cell Biology.

[27]  A. Gerdes,et al.  Myocyte Redistribution of GRK2 and GRK5 in Hypertensive, Heart-Failure–Prone Rats , 2002, Hypertension.

[28]  S. Molotchnikoff,et al.  Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors , 2002, Circulation research.

[29]  Liang-sheng Lu,et al.  [Expression of fusion proteins in beta(2)GP I gene-transfected HEp-2 cells and its clinical application]. , 2002, Zhonghua yi xue za zhi.

[30]  T. Hammond,et al.  Ang II Accumulation in Rat Renal Endosomes During Ang II-Induced Hypertension: Role of AT1 Receptor , 2002, Hypertension.

[31]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[32]  G. Eisenhofer.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[33]  S. Schulz,et al.  Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.

[34]  Z. Freyberg,et al.  Intracellular localization of phospholipase D1 in mammalian cells. , 2001, Molecular biology of the cell.

[35]  L. Brunton,et al.  Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. , 2001, Annual review of pharmacology and toxicology.

[36]  V. Barr,et al.  Nuclear Localization of G Protein β5 and Regulator of G Protein Signaling 7 in Neurons and Brain* , 2001, The Journal of Biological Chemistry.

[37]  L. Gerace,et al.  Gradient of Increasing Affinity of Importin β for Nucleoporins along the Pathway of Nuclear Import , 2001, The Journal of cell biology.

[38]  M. Lisanti,et al.  Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. , 2000, The Journal of biological chemistry.

[39]  J. Raymond,et al.  A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. , 2000, American journal of physiology. Renal physiology.

[40]  M. Crouch,et al.  Nuclear and cytoskeletal translocation and localization of heterotrimeric G‐proteins , 2000, Immunology and cell biology.

[41]  S. Steinberg.  The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. , 1999, Circulation research.

[42]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[43]  G. Rappold,et al.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.

[44]  I. Buchwalow,et al.  Adenylyl cyclase in the heart: An enzymocytochemical and immunocytochemical approach , 1998, Microscopy research and technique.

[45]  K. Kawamura,et al.  Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry , 1998, Microscopy research and technique.

[46]  W. Giles,et al.  A rapidly activating sustained K+ current modulates repolarization and excitation–contraction coupling in adult mouse ventricle , 1997, The Journal of physiology.

[47]  C. Adler,et al.  DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. , 1997, Cardiovascular research.

[48]  S. Rhee,et al.  The Role of Carboxyl-terminal Basic Amino Acids in Gqα-dependent Activation, Particulate Association, and Nuclear Localization of Phospholipase C-β1* , 1996, The Journal of Biological Chemistry.

[49]  P. Molenaar,et al.  Differences between the third cardiac β‐adrenoceptor and the colonic β3‐adrenoceptor in the rat , 1996 .

[50]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[51]  William L. Smith,et al.  Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.

[52]  I. Haas,et al.  BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum , 1994, Experientia.

[53]  H. Erickson,et al.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C , 1994, The Journal of cell biology.

[54]  R. Lefkowitz,et al.  Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. , 1994, Molecular pharmacology.

[55]  P. Chidiac,et al.  Inverse agonist activity of beta-adrenergic antagonists. , 1994, Molecular pharmacology.

[56]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[57]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[58]  S. Patierno,et al.  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: Relationship to RNA polymerase arrest , 2004, Molecular and Cellular Biochemistry.

[59]  M. Bouvier,et al.  Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. , 2004, The Journal of biological chemistry.

[60]  Jean-François Mercier,et al.  Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. , 2002, The Journal of biological chemistry.

[61]  Keith W. Jones,et al.  Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α , 2001 .

[62]  D. Lu,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Angiotensin II-Induced Nuclear Targeting of the Angiotensin Type 1 (AT 1) Receptor in Brain Neurons* , 2022 .

[63]  P. Falardeau,et al.  Norepinephrine in neonatal rat ventricular myocytes: association with the cell nucleus and binding to nuclear alpha 1- and beta-adrenergic receptors. , 1993, Journal of molecular and cellular cardiology.